.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Colorcon
Cerilliant
Farmers Insurance
Fish and Richardson
Cantor Fitzgerald
Deloitte
Boehringer Ingelheim
Moodys
Chubb

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,360,522

« Back to Dashboard

Details for Patent: 4,360,522

Title: Purine derivatives
Abstract:9-Hydroxyethoxymethyl (and related) derivatives of certain 6-, and 2,6-substituted purines have been discovered to have potent anti-viral activities. Novel compounds and their pharmaceutically acceptable salts, pharmaceutical formulations containing the compounds of this invention, and the treatment of viral infections with these formulations are all disclosed. 9-(2-hydroxyethoxymethyl) guanine and 2-amino-9-(2-hydroxyethoxymethyl)adenine are examples of especially active compounds of this invention.
Inventor(s): Schaeffer; Howard J. (Raleigh, NC)
Assignee: Burroughs Wellcome Co. (Research Triangle Park, NC)
Filing Date:Feb 01, 1978
Application Number:05/874,067
Claims:1. A substituted purine of formula ##STR12## wherein X is sulphur or oxygen; R.sup.1 is halogen, hydrogen, thio,alkylthio, alkoxy or azide; R.sup.2 is hydrogen, halogen, amino or azide; R.sup.3 is nitrogen, straight or branched chain or cyclic alkyl, hydroxyalkyl, benzyloxyalkyl or phenyl; R.sup.4 is hydrogen, hydroxy, or lower alkyl; R.sup.5 is hydrogen, hydroxy, amino, alkyl, hydroxyalkyl, benzoyloxy, benzoyloxymethyl, benzyloxy, sulphamoyloxy, phosphate, carboxypropionyloxy, or acetoxy; and R.sup.6 is hydrogen alkyl, hydroxyalkyl or a pharmaceutically acceptable salt thereof.

2. A substituted purine of formula (I) according to claim 1 wherein X is an oxygen atom.

3. A method of treating a susceptible viral infection in a mammal which comprises administering an effective non-toxic amount of the compound or a pharmaceutically acceptable salt of claim 1.

4. The method of claim 3 in which X is oxygen.

5. The method of claim 4 in which R.sup.1 is chlorine, R.sup.2 is amino, R.sup.5 is benzoyloxy and R.sup.3, R.sup.4 and R.sup.6 are hydrogen.

6. The method of claim 3 in which the viral infection is a herpes virus infection.

7. The method of claim 5 in which the viral infection is a herpes virus infection.

8. A pharmaceutical composition comprising an effective anti-viral amount of the compound or salt of claim 1 and a pharmaceutically acceptable carrier therefore.

9. The composition of claim 8 in which X is oxygen.

10. The composition of claim 8 in which the amount is an effective anti-herpes amount.

11. The composition of claim 8 in a form for oral or topical administration.

12. A compound of formula (I) ##STR13## wherein R.sup.1 is chlorine, R.sup.2 is amino, R.sup.5 is benzoyloxy and R.sup.3, R.sup.4 and R.sup.6 are each hydrogen or a pharmaceutically acceptable salt thereof, wherein X is oxygen.

13. A method of treating a susceptible viral infection in a mammal which comprises administering an effective non-toxic amount of the compound or salt of claim 12.

14. A pharmaceutical composition comprising an effective anti-viral amount of the compound or salt of claim 12 and a pharmaceutically acceptable carrier therefor.

15. The compound of the formula I ##STR14## wherein X is sulphur or oxygen; R.sup.1 is hydrogen, halogen, hydroxy, alkoxy, azide, thio, or alkylthio; R.sup.2 is hydrogen, halogen, alkylthio, amino or azide, provided R.sup.2 is not amino when R.sup.1 is hydroxy; R.sup.3 is hydrogen, straight or branched chain or cyclic alkyl, hydroxyalkyl, benzyloxyalkyl or phenyl, R.sup.4 is hydrogen, hydroxy or alkyl; R.sup.5 is hydrogen hydroxy, amino, alkyl, hydroxyalkyl, benzyloxy, benzoyloxy, benzoyloxymethyl, sulphamoyloxy, phosphate, or straight or branched chain or cyclic acyloxy having from 1 to 8 carbon atoms; R.sup.6 is hydrogen or alkyl; or a pharmaceutically acceptable salt thereof.

16. The compound or salt of claim 15 wherein R.sup.5 is straight or branched chain or cyclic acyloxy having from 1 to 8 carbon atoms.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Express Scripts
Colorcon
Accenture
Covington
Merck
Dow
Julphar
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot